HSP90B2P and cancer: We identified 1513 significant HSP enrichments (FDR < 0.05), of which 749 were positive enrichments (promoting EMT) and 764 were negative enrichments (suppressing EMT) from all HSPs (100%, 82/82), suggesting dual functional effects of HSPs in cancer metastasis (Fig. 4a).